Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from InhaleRx Limited ( (AU:IRX) ) is now available.
InhaleRx Limited announced a change in the director’s interest, specifically involving Sean Williams, who is a director and beneficiary of certain trusts. The change involved an off-market transfer of 750,000 fully paid ordinary shares between Mr. Williams’ indirect holdings, with no change in the total number of shares held. This adjustment in shareholding does not affect the overall number of securities held by Mr. Williams, maintaining his position within the company.
More about InhaleRx Limited
InhaleRx Limited operates in the healthcare industry, focusing on the development and commercialization of inhalation technologies and products. The company aims to provide innovative solutions for respiratory health, targeting both consumer and medical markets.
Average Trading Volume: 216,833
Technical Sentiment Signal: Sell
Current Market Cap: A$5.76M
See more data about IRX stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue